Media Inquiries
Sort by Year
September 18, 2019
Ironwood Pharmaceuticals and AstraZeneca Amend LINZESS® (linaclotide) Collaboration in China
August 13, 2019
Ironwood Pharmaceuticals Announces Full Exercise of Convertible Notes Over-Allotment
August 8, 2019
Ironwood Pharmaceuticals Announces Pricing of Upsized $350 Million Convertible Senior Notes Offering
August 6, 2019
Ironwood Pharmaceuticals Announced Proposed Offering of $330 Million of Convertible Senior Notes
May 9, 2019
Ironwood Pharmaceuticals to Highlight IW-3718 and Linaclotide Data at Digestive Disease Week® 2019
May 7, 2019
Ironwood Pharmaceuticals to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference